All Stories

  1. Evaluating Post-Radiotherapy Laryngeal Function with Laryngeal Videostroboscopy in Early Stage Glottic Cancer

    Article • Frontiers in Oncology, June 2017, Frontiers

    Dr. Ariel E Marciscano

  2. LAG3 (CD223) as a cancer immunotherapy target

    Article • Immunological Reviews, March 2017, Wiley

    Dr. Ariel E Marciscano

  3. Long-term Outcomes With Planned Multistage Reduced Dose Repeat Stereotactic Radiosurgery for Treatment of Inoperable High-Grade Arteriovenous Malformations: An Observational Retrospective Cohort Study

    Article • Neurosurgery, February 2017, Oxford University Press (OUP)

    Dr. Ariel E Marciscano

  4. Abstract PR03: Prophylactic nodal irradiation abrogates the synergy of tumor radiotherapy and immune checkpoint blockade

    Article • Cancer Immunology Research, February 2017, American Association for Cancer Research (AACR)

    Dr. Ariel E Marciscano

  5. Significant Differences in Planning Target Volumes Based on Immediate Postoperative Imaging Versus Radiation Therapy Planning Imaging: Implications for Treatment Planning for Malignant Glioma

    Article • International Journal of Radiation Oncology*Biology*Physics, October 2016, Elsevier

    Dr. Ariel E Marciscano

  6. Does Prophylactic Nodal Irradiation Inhibit Potential Synergy Between Radiation Therapy and Immunotherapy?

    Article • International Journal of Radiation Oncology*Biology*Physics, October 2016, Elsevier

    Dr. Ariel E Marciscano

  7. Postoperative spine IG-HSRT outcomes

    Article • March 2016, Taylor & Francis

    Dr. Ariel E Marciscano

  8. Benign meningiomas (WHO Grade I) with atypical histological features: correlation of histopathological features with clinical outcomes

    Article • Journal of Neurosurgery, January 2016, Journal of Neurosurgery Publishing Group (JNSPG)

    Dr. Ariel E Marciscano

  9. Imaging and extent of surgical resection predict risk of meningioma recurrence better than WHO histopathological grade

    Article • Neuro-Oncology, November 2015, Oxford University Press (OUP)

    Dr. Ariel E Marciscano

  10. MNGO-05IMAGING AND EXTENT OF SURGICAL RESECTION PREDICT RISK OF MENINGIOMA RECURRENCE BETTER THAN WHO HISTOPATHOLOGICAL GRADE

    Article • Neuro-Oncology, November 2015, Oxford University Press (OUP)

    Dr. Ariel E Marciscano

  11. Immediate Versus Delayed Treatment Does Not Influence Long-term Outcomes After Radiation Therapy for Vestibular Schwannoma

    Article • International Journal of Radiation Oncology*Biology*Physics, November 2015, Elsevier

    Dr. Ariel E Marciscano

  12. Concurrent Immunotherapy and Stereotactic Radiosurgery for Brain Metastases Is Associated With a Decreased Incidence of New Intracranial Metastases

    Article • International Journal of Radiation Oncology*Biology*Physics, November 2015, Elsevier

    Dr. Ariel E Marciscano

  13. Correlation of Imaging Characteristics With Histopathological WHO Grade in Meningiomas

    Article • International Journal of Radiation Oncology*Biology*Physics, November 2015, Elsevier

    Dr. Ariel E Marciscano

  14. Long-term Treatment Response and Patient Outcomes for Vestibular Schwannoma Patients Treated With Hypofractionated Stereotactic Radiation Therapy

    Article • International Journal of Radiation Oncology*Biology*Physics, November 2015, Elsevier

    Dr. Ariel E Marciscano

  15. Evaluating Radiological Changes in Vestibular Schwannoma Patients Treated With Hypofractionated Stereotactic Radiation Therapy: A Potential Role for a Novel 3-D Quantitative Volumetric Assessment Tool

    Article • International Journal of Radiation Oncology*Biology*Physics, November 2015, Elsevier

    Dr. Ariel E Marciscano

  16. 3D quantitative assessment of response to fractionated stereotactic radiotherapy and single-session stereotactic radiosurgery of vestibular schwannoma

    Article • European Radiology, July 2015, Springer Science + Business Media

    Dr. Ariel E Marciscano

  17. Development of a novel multiplexed assay for quantification of transforming growth factor-β(TGF-β)

    Article • Growth Factors, January 2015, Informa Healthcare

    Dr. Ariel E Marciscano

  18. Antiangiogenic Therapies and Extracranial Metastasis in Glioblastoma: A Case Report and Review of the Literature

    Article • Case Reports in Oncological Medicine, January 2015, Hindawi Publishing Corporation

    Dr. Ariel E Marciscano

  19. Stereotactic body radiation therapy in pancreatic cancer: the new frontier

    Article • Expert Review of Anticancer Therapy, September 2014, Informa Healthcare

    Dr. Ariel E Marciscano

  20. Video Laryngostroboscopy Demonstrates Post–Radiation Therapy Improvement in Dysphonia in Early-Stage Glottic Larynx Cancer

    Article • International Journal of Radiation Oncology*Biology*Physics, September 2014, Elsevier

    Dr. Ariel E Marciscano

  21. Long-Term Follow-Up of Adaptive Multistage Stereotactic Radiosurgery for Treatment of High-Grade Arteriovenous Malformations

    Article • International Journal of Radiation Oncology*Biology*Physics, September 2014, Elsevier

    Dr. Ariel E Marciscano

  22. Benign Meningiomas With Atypical Features: Correlation of Histopathological Features With Clinical Outcomes

    Article • International Journal of Radiation Oncology*Biology*Physics, October 2013, Elsevier

    Dr. Ariel E Marciscano

  23. Is there a role for an external beam boost in cervical cancer radiotherapy?†

    Article • Frontiers in Oncology, January 2013, Frontiers

    Dr. Ariel E Marciscano

  24. Resistance of Glioblastoma-Initiating Cells to Radiation Mediated by the Tumor Microenvironment Can Be Abolished by Inhibiting Transforming Growth Factor- 

    Article • Cancer Research, June 2012, American Association for Cancer Research (AACR)

    Dr. Ariel E Marciscano

  25. Management of High-Risk Localized Prostate Cancer

    Article • Advances in Urology, January 2012, Hindawi Publishing Corporation

    Dr. Ariel E Marciscano

  26. Abstract A87: Preliminary results of a phase II study of erlotinib combined with adjuvant chemoradiation and chemotherapy in patients with resectable pancreatic cancer.

    Article • Molecular Cancer Therapeutics, November 2011, American Association for Cancer Research (AACR)

    Dr. Ariel E Marciscano

  27. Development of a Novel Multiplexed-TGFβ Assay

    Article • International Journal of Radiation Oncology*Biology*Physics, October 2011, Elsevier

    Dr. Ariel E Marciscano

  28. Brachytherapy versus External Beam Boost in Cervical Cancer Radiotherapy

    Article • International Journal of Radiation Oncology*Biology*Physics, October 2011, Elsevier

    Dr. Ariel E Marciscano

  29. TGFβ Inhibition Radiosensitizes Murine Glioblastoma Cells and Decreases Neurosphere-forming Capacity

    Article • International Journal of Radiation Oncology*Biology*Physics, October 2011, Elsevier

    Dr. Ariel E Marciscano

  30. Introduction to the Medical Professions Through an Innovative Medical Student-Run Pipeline Program

    Article • Journal of the National Medical Association, September 2011, Elsevier

    Dr. Ariel E Marciscano

  31. Abstract LB-361: Radiosensitization and decreased neurosphere-forming capacity with TGF  inhibition in glioma cells

    Article • Cancer Research, April 2011, American Association for Cancer Research (AACR)

    Dr. Ariel E Marciscano